Revision: Nov. 16, 2023, 1:57 p.m.
2024 SESSION
24-2852.0
05/06
SENATE BILL [bill number]
AN ACT relative to newborn screening for cytomegalovirus.
SPONSORS: [sponsors]
COMMITTEE: [committee]
─────────────────────────────────────────────────────────────────
ANALYSIS
This bill requires newborn screening for cytomegalovirus.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
24-2852.0
05/06
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty Four
AN ACT relative to newborn screening for cytomegalovirus.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 Newborn Screening for Cytomegalovirus. Amend the introductory paragraph of RSA 132:10-a, I to read as follows:
I. The physician, hospital, nurse midwife, midwife, or other health care provider attending a newborn child shall test a newborn child for metabolic disorders. Such tests shall include, but not be limited to, phenylketonuria, galactosemia, homocystinuria, maple syrup urine disease, [and] hypothyroidism, and cytomegalovirus. Additional disorders shall be added to the newborn screening panel based upon, but not limited to, the following considerations: